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Abstract
Background:  Statistical power calculations inform the design and interpretation of genetic
association studies, but few programs are tailored to case-control studies of single nucleotide
polymorphisms (SNPs) in unrelated subjects.
Results: We have developed the "Power for Genetic Association analyses" (PGA) package which
comprises algorithms and graphical user interfaces for sample size and minimum detectable risk
calculations using SNP or haplotype effects under different genetic models and study constrains.
The software accounts for linkage disequilibrium and statistical multiple comparisons. The results
are presented in graphs or tables and can be printed or exported in standard file formats.
Conclusion: PGA is user friendly software that can facilitate decision making for association
studies of candidate genes, fine-mapping studies, and whole-genome scans. Stand-alone executable
files and a Matlab toolbox are available for download at: http://dceg.cancer.gov/bb/tools/pga
Background
Case-control genetic association studies are increasingly
being used in studying the genetic basis of human com-
plex traits [1-3]. Statistical power analyses constitute a key
step in the design process of these studies. Power calcula-
tions elucidates the actual sample size needed to find a
true genotype-phenotype correlation under the study con-
straints [4]. Indeed, most grants applications for genetic
association studies require a power analysis section to jus-
tify the research proposal. Alternatively, power analysis
can be used to explore possible reasons for equivocal or
negative results. Thus, it is an indispensable procedure
both for a priori and a posteriori analyses in genetic associ-
ation studies.
The principals for power calculation can be found in
standard statistical textbooks. Moreover, the scientific lit-
erature describes the mathematics of power analyses for a
variety of specialized experimental designs [4-6]. Yet,
there is limited computer-software to assist scientists in
this task [7]. Many commonly used computational tools
for genetic studies are oriented towards family-based stud-
ies [8-11] and only few have been developed to handle
power calculations for case-control studies of single nucle-
otide polymorphisms (SNPs) in unrelated subjects [12-
14]. Since the latter approach is increasingly used, we have
developed algorithms and graphical user interfaces
(GUIs) to calculate the sample size and the minimum
detectable relative risk in genetic case-control studies for
dominant, co-dominant, and recessive models of SNPs
and SNP haplotypes.
Published: 13 May 2008
BMC Genetics 2008, 9:36 doi:10.1186/1471-2156-9-36
Received: 24 January 2008
Accepted: 13 May 2008
This article is available from: http://www.biomedcentral.com/1471-2156/9/36
© 2008 Menashe et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Genetics 2008, 9:36 http://www.biomedcentral.com/1471-2156/9/36
Page 2 of 5
(page number not for citation purposes)
Implementation
The "Power for Genetic Association Analyses" (PGA)
package was developed in Matlab and consists a toolbox
of command line functions and three unifying graphical
user interfaces (GUIs). Users with a Matlab software can
run the three GUIs or the command line functions in Mat-
lab environment. Users without a Matlab license can
download and install the compiled versions of the three
GUIs that run as stand-alone applications under Windows
XP or Vista operating systems.
The program assumes that SNPs are biallelic and in
Hardy-Weinberg equilibrium. All statistical tests are two-
sided. The GUIs called PGA1 and PGA2 can display up to
9 scenarios simultaneously. Hence, they can be used to
identify a robust choice of sample size. The graphs pro-
duced by each GUI can be printed or exported as TIF files,
and tables of numerical results can be exported as HTML
or csv files.
Results
The GUI called PGA1 provides a computational and
graphical interface for the relation between statistical
power and sample size for dominant, co-dominant and
recessive SNP or haplotype effect (Figure 1A). The geno-
typed markers can include the causative SNP, or be in
linkage disequilibrium (LD) with the causal SNP at a
given level. The impact of multiple hypothesis testing can
be accomplished by adjusting the effective degrees of free-
dom (EDF) or the alpha level. For example, in a fine-map-
ping study of 200 effective tests (see below), the sample
size required to detect an overall 2-fold increase in risk
(assuming a co-dominant model with 1 df) with 90%
power, false positive rate of 5%, disease prevalence of 7%,
disease allele frequency of 5%, and assuming a complete
LD between the genotyped marker and the causative SNP
(r2 = 1.0) is 800 cases and 800 controls (Figure 1A). PGA1
allows one to explore the impact of different parameters.
For example, reducing the genotype relative risk from 2-
fold to 1.7-fold in the same study, increases the required
sample size from 800 to 1400 cases and controls. PGA1 is
designed to execute power calculations for haplotype
data. For example, using the same parameters in the exam-
ple above and assuming 12 common haplotypes in an LD
block within the region show that the required sample
size would be 600 and 1100 cases and controls to attain
90% power for relative risks of 2 and 1.7 respectively (Fig-
ure 1A).
The GUI PGA2 has a similar interface to PGA1, but it is
designed to calculate and plot the minimum detectable
relative risk (MDRR) for genetic loci, given a fixed number
of cases and controls, according to their minor allele fre-
quencies (MAFs). MDRR can calculate the smallest rela-
tive risk that can be detected, with sample in hand, at the
target level of power. Hence, PGA2 can assist in designing
fine mapping studies of prominent genomic loci, identi-
fied from familial linkage analyses or genome-wide asso-
ciation studies. For example, multiple markers along a
600-kb segment on human chromosome 8q24 have
recently been associated with prostate cancer susceptibil-
ity [15-17]. Consequently, one may want to genotype
additional SNPs in this region aiming to find the most
strongly associated markers as a prelude to functional or
comparative studies. Given a fixed sample size, there is a
detection limit such that one is under-powered to detect
true associations to SNPs with MAF below a certain
threshold. Considerable resources can be saved by exclud-
ing SNPs with MAF below the detection threshold. For
example, using the PGA2 tool reveals that with a sample
size of 500 cases and controls and assuming an effective
number of tests (effective degrees of freedom – EDF) of
500, there is no justification (power < 90%) to genotype
SNPs with minor allele frequency (MAF) < 0.08 assuming
a modest relative risk of ~2-fold as implied by the prelim-
inary studies [15-17] (Figure 1B).
An important utility for PGA1 and PGA2 is the GUI EDF,
which calculates the effective degrees of freedom (EDF)
for a particular set of SNP genotypes in linkage disequilib-
rium. This tool allows the user to assess the extent of mul-
tiple testing that is often overestimated or underestimated
in naive power analyses. The EDF calculator accepts as
input genotype data files from Hapmap [18] or tab-delim-
ited text files. It calculates and maps the linkage disequi-
librium patterns (r2) among the SNPs in the dataset, and
from these data computes a summary measure of the EDF
[19] (Figure 2). The value of EDF can then be used in
PGA1 and PGA2 to precisely calibrate the calculations to
the specific SNPs under consideration by a given study. It
is important to note that other methods accounting for
linkage disequilibrium between genetic markers as well as
other approaches for multiple testing adjustments can be
incorporated into the PGA calculations (see Additional
file 1).
All the procedures included in the PGA GUIs are available
in a single Matlab toolbox and can be executed at the Mat-
lab command line. This allows Matlab users to use some
of the incorporated functions in their own Matlab scripts.
For example, to calculate EDF for 100 different regions
with 80 SNPs each, took ~176 sec to run using a Windows
XP dual 3.19 GHz, Intel Xion workstation.
Discussion
The PGA package is well suited for power calculations
where relatively small genomic regions are scanned for
disease susceptibility loci. However, it can also be used to
assess larger regions and even genome-wide association
studies, via appropriate specification of the false positiveBMC Genetics 2008, 9:36 http://www.biomedcentral.com/1471-2156/9/36
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Graphical user interfaces for statistical power calculations Figure 1
Graphical user interfaces for statistical power calculations. (A) PGA1 – statistical power is calculated and plotted for 
different sample sizes and various genetic and statistical parameters. Input variables (e.g. 'Genetic mode of inheritance', 'disease 
allele frequency', 'relative risk (RR)', etc.) can be specified using slider controls, or by typing specific values in the corresponding 
text boxes. Pressing the 'Run' button executes the calculations and plots the relationships between power and sample size 
according to the specified study parameters. A keyed legend listing the corresponding parameters is shown on the graph. Up to 
eight different analyses (color-coded) can be displayed simultaneously, allowing the comparison of different scenarios. (B) 
PGA2 – Minimal detectable relative risk (MDRR) is calculated and plotted for various minor allele frequencies (MAFs) of poten-
tial genotyped loci. Input and output is similar to PGA1.BMC Genetics 2008, 9:36 http://www.biomedcentral.com/1471-2156/9/36
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rate, i.e. α/m where m is the number of genotyped mark-
ers in the study. Similarly to other popular software in this
field [12-14], PGA incorporates basic power and sample
size calculations for various genetic models and presents
the results 'on the fly' in graphs and tables. In addition, it
offers unique power analyses for haplotype data using the
method of Chen et. al. [20]. Another novel feature is the
calculation of minimal detectable risk over a range of
marker allele frequencies, implemented in the PGA2 GUI.
This tool may become extremely important in the current
phase of genetic association studies where a large number
of diseases-susceptibility genomic loci are revealed by
genome-wide association studies (GWAS) [21-23]. These
regions are expected to be further investigated in higher
resolution, using a denser set of makers, in efforts to iden-
tify the actual predisposing genetic variation of these dis-
eases. In this realm, PGA2 would facilitate the design of
these studies by assessing power at the lower allele fre-
quency threshold under consideration. Finally, the assess-
ment of effective degrees of freedom for a particular
genomic region or set of SNPs, as implemented in the GUI
EDF, provides power calculation for procedures such as
the minP test [20] that are more powerful than the con-
servative Bonferroni procedure. The incorporation of
other methods for multiple testing adjustments (e.g. false
discovery rate [24]) in automatic power calculation tools
is more complex and requires specification of parameters
such as the number of associated versus null SNPs and the
magnitude of any effects. These calculations might be use-
ful, especially for genome-wide association studies, but
they are currently not in the scope of PGA.
Other freely-available software packages have features
that are complimentary to PGA (see Additional file 2). The
novel features of PGA are especially relevant to studies of
candidate genes and fine-mapping efforts.
Conclusion
The PGA package assembles a broad spectrum of statisti-
cal power calculations for genetic association studies in a
single Matlab toolbox and three stand-alone GUIs. The
software offers user-friendly tools for advanced calcula-
tions of statistical power and sample size and presents the
results 'on the fly' in graphs and tables. Hence, PGA may
significantly facilitate decision making and interpretation
of association studies of candidate genes, fine-mapping
studies, and genome-wide scans.
Availability and requirements
• Project name: Power for genetic association analyses
(PGA).
•  Project home page: http://dceg.cancer.gov/bb/tools/
pga
• Operating system(s): Windows XP & Vista.
• Programming language: Matlab.
• Other requirements: To run the stand-alone GUIs, users
without Matlab licenses should install first the MATLAB
Component Runtime (MCR) that is available in the PGA
home page.
• Any restrictions to use by non-academics: None
• Reviewers access to the software: reviewers can down-
load the software in a way that preserves their anonymity,
through the following links:
Readme file: http://dceg.cancer.gov/bb/tools/pga/readme
PGA.exe file: http://dceg.cancer.gov/PGA/pga.exe.
Effective degrees of freedom calculator Figure 2
Effective degrees of freedom calculator. (A) HapMap 
SNP genotype data from human chromosome 8q24 
(chr8:128100000-128700000) is used as an input. The calcu-
lated EDF for SNPs with MAF > 0.05 in this dataset is 608. 
(B) LD map for the selected SNPs is also displayed in the out-
put.BMC Genetics 2008, 9:36 http://www.biomedcentral.com/1471-2156/9/36
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MCRinstaller file: http://dceg.cancer.gov/PGA/MCRIn
staller.exe
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